Catalent Net Profit Margin 2012-2019 | CTLT

Current and historical net profit margin for Catalent (CTLT) from 2012 to 2019. Net profit margin can be defined as net Income as a portion of total sales revenue. Catalent net profit margin for the three months ending March 31, 2019 was .
Catalent Net Profit Margin Historical Data
Date TTM Revenue TTM Net Income Net Margin
2019-03-31 $2.48B $0.15B 6.05%
2018-12-31 $2.49B $0.14B 5.51%
2018-09-30 $2.47B $0.07B 2.67%
2018-06-30 $2.46B $0.08B 3.41%
2018-03-31 $2.40B $0.06B 2.63%
2017-12-31 $2.30B $0.07B 3.04%
2017-09-30 $2.18B $0.11B 5.00%
2017-06-30 $2.08B $0.11B 5.30%
2017-03-31 $1.99B $0.11B 5.32%
2016-12-31 $1.90B $0.09B 4.80%
2016-09-30 $1.87B $0.11B 5.62%
2016-06-30 $1.85B $0.11B 6.06%
2016-03-31 $1.83B $0.21B 11.39%
2015-12-31 $1.84B $0.23B 12.48%
2015-09-30 $1.84B $0.25B 13.34%
2015-06-30 $1.83B $0.21B 11.63%
2015-03-31 $1.84B $0.09B 4.67%
2014-12-31 $1.85B $0.06B 3.30%
2014-09-30 $1.83B $-0.01B -0.27%
2014-06-30 $1.83B $0.02B 0.93%
2014-03-31 $1.31B $-0.01B -0.76%
2013-12-31 $0.86B $-0.02B -1.99%
2013-09-30 $0.41B $0.00B 0.48%
2013-06-30 $0.00B 0 nan%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $6.729B $2.463B
Catalent, Inc. provides advanced delivery technologies and development solutions for drugs, biologics and consumer health products. It operates through Oral Technologies, Medication Delivery Solutions, and Development & Clinical Services. The Oral Technologies segment address the full diversity of the pharmaceutical industry including small molecules, large molecule biologics and consumer health products. The Medication Delivery Solutions segment offers formulation, development, and manufacturing services for delivery of drugs and biologics administered through injection, inhalation, and ophthalmic routes. The Development and Clinical Services segment provides manufacturing, packaging, storage, and inventory management services for drugs and biologics in clinical trials. Catalent, Inc. is headquartered in Somerset, New Jersey.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $49.273B 31.48
Takeda Pharmaceutical (TAK) Japan $27.310B 8.02
Grifols (GRFS) Spain $12.644B 15.99
Ionis Pharmaceuticals (IONS) United States $9.621B 21.03
Sage Therapeutics (SAGE) United States $8.999B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $7.985B 10.94
Neurocrine Biosciences (NBIX) United States $7.284B 0.00
Nektar Therapeutics (NKTR) United States $5.834B 9.51
Tilray (TLRY) Canada $4.476B 0.00
Taro Pharmaceutical Industries (TARO) Israel $4.018B 14.10
United Therapeutics (UTHR) United States $3.814B 0.00
FibroGen (FGEN) United States $3.071B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.578B 9.28
PTC Therapeutics (PTCT) United States $2.360B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $2.066B 311.29
Portola Pharmaceuticals (PTLA) United States $1.962B 0.00
Xencor (XNCR) United States $1.884B 51.45
Tricida (TCDA) United States $1.846B 0.00
Aerie Pharmaceuticals (AERI) United States $1.842B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.838B 25.12
Pacira Pharmaceuticals (PCRX) United States $1.795B 86.92
USANA Health Sciences (USNA) United States $1.765B 15.34
Ironwood Pharmaceuticals (IRWD) United States $1.751B 0.00
Zogenix (ZGNX) United States $1.656B 0.00
Madrigal Pharmaceuticals (MDGL) United States $1.521B 0.00
Endo (ENDP) Ireland $1.429B 2.30
Heron Therapeutics (HRTX) United States $1.389B 0.00
Esperion Therapeutics (ESPR) United States $1.374B 0.00
Corcept Therapeutics (CORT) United States $1.172B 16.72
TURNING PT THER (TPTX) United States $1.147B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.078B 0.00
Radius Health (RDUS) United States $0.942B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.862B 0.00
ArQule (ARQL) United States $0.788B 0.00
TherapeuticsMD (TXMD) United States $0.767B 0.00
Aptorum Group (APM) China $0.715B 0.00
ChemoCentryx (CCXI) United States $0.684B 0.00
Akebia Therapeutics (AKBA) United States $0.656B 0.00
ORGANOGENESIS (ORGO) United States $0.647B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.640B 0.00
CannTrust Holdings (CTST) Canada $0.623B 0.00
Odonate Therapeutics (ODT) United States $0.603B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.595B 0.00
Dermira (DERM) United States $0.534B 0.00
GlycoMimetics (GLYC) United States $0.513B 0.00
Flexion Therapeutics (FLXN) United States $0.491B 0.00
Siga Technologies (SIGA) United States $0.472B 1.11
Corbus Pharmaceuticals Holdings (CRBP) United States $0.471B 0.00
Translate Bio (TBIO) United States $0.460B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.452B 22.85
Mast Therapeutics (SVRA) United States $0.400B 0.00
KalVista Pharmaceuticals (KALV) United States $0.399B 0.00
Forty Seven (FTSV) United States $0.391B 0.00
Collegium Pharmaceutical (COLL) United States $0.390B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.379B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.365B 0.00
OptiNose (OPTN) United States $0.358B 0.00
Karyopharm Therapeutics (KPTI) United States $0.352B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.343B 0.00
Xeris Pharmaceuticals (XERS) United States $0.336B 0.00
TCR2 Therapeutics (TCRR) United States $0.332B 0.00
CASI Pharmaceuticals (CASI) United States $0.308B 0.00
ImmunoGen (IMGN) United States $0.289B 0.00
Harpoon Therapeutics (HARP) United States $0.283B 0.00
Molecular Templates (MTEM) United States $0.279B 0.00
Dova Pharmaceuticals (DOVA) United States $0.274B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.260B 0.00
Concert Pharmaceuticals (CNCE) United States $0.257B 0.00
Lannett Co Inc (LCI) United States $0.238B 2.31
Aratana Therapeutics (PETX) United States $0.236B 0.00
Calithera Biosciences (CALA) United States $0.233B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.229B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.229B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.224B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.221B 0.00
MEI Pharma (MEIP) United States $0.217B 0.00
Rafael Holdings (RFL) United States $0.215B 0.00
Minerva Neurosciences (NERV) United States $0.211B 0.00
Aclaris Therapeutics (ACRS) United States $0.209B 0.00
Recro Pharma (REPH) United States $0.207B 0.00
Aldeyra Therapeutics (ALDX) United States $0.200B 0.00
IMV INC (IMV) Canada $0.199B 0.00
Opexa Therapeutics (ACER) United States $0.197B 0.00
Galectin Therapeutics (GALT) United States $0.194B 0.00
Nature's Sunshine Products (NATR) United States $0.191B 61.88
Ardelyx (ARDX) United States $0.176B 0.00
Taiwan Liposome, Unsponsored ADR (TLC) Taiwan $0.172B 0.00
Jounce Therapeutics (JNCE) United States $0.167B 0.00
Redhill Biopharma (RDHL) Israel $0.166B 0.00
Majesco Entertainment (PTE) United States $0.163B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.155B 0.00
Tyme Technologies (TYME) United States $0.151B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.142B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.141B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.138B 0.00
Neon Therapeutics (NTGN) United States $0.130B 0.00
Bio Blast Pharma (ENLV) Israel $0.120B 0.00
DURECT (DRRX) United States $0.116B 0.00
Aquestive Therapeutics (AQST) United States $0.115B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.115B 0.00
Ocular Therapeutix (OCUL) United States $0.114B 0.00
MediWound (MDWD) Israel $0.112B 0.00
Nivalis Therapeutics (ALPN) United States $0.106B 0.00
ProNAi Therapeutics (SRRA) Canada $0.105B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.099B 71.11
Zafgen (ZFGN) United States $0.099B 0.00
Cardiome Pharma (CORV) Canada $0.099B 0.00
Champions Oncology (CSBR) United States $0.098B 0.00
AgeX Therapeutics (AGE) United States $0.097B 0.00
Natural Alternatives (NAII) United States $0.096B 9.62
China SXT Pharmaceuticals (SXTC) China $0.093B 0.00
Iterum Therapeutics (ITRM) Ireland $0.091B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.085B 0.00
Infinity Pharmaceuticals (INFI) United States $0.084B 0.00
Neos Therapeutics (NEOS) United States $0.083B 0.00
Otonomy (OTIC) United States $0.082B 0.00
Adherex Technologies (FENC) United States $0.082B 0.00
ElectroCore (ECOR) United States $0.080B 0.00
Avenue Therapeutics (ATXI) United States $0.078B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.077B 0.00
Oasmia Pharmaceutical AB (OASM) Sweden $0.070B 0.00
SCYNEXIS (SCYX) United States $0.068B 0.00
Capnia (SLNO) United States $0.065B 0.00
Genocea Biosciences (GNCA) United States $0.063B 0.00
Novan (NOVN) United States $0.060B 0.00
Ampio Pharmaceuticals (AMPE) United States $0.060B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.055B 0.00
CTI BioPharma (CTIC) United States $0.050B 0.00
KemPharm (KMPH) United States $0.048B 0.00
Forward Pharma (FWP) Denmark $0.048B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.047B 0.00
Actinium Pharmaceuticals (ATNM) United States $0.047B 0.00
AIT Therapeutics (AITB) Israel $0.045B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.044B 0.00
India Globalization Capital (IGC) United States $0.044B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.043B 0.00
BioLineRx (BLRX) Israel $0.043B 0.00
Bio-Path Holdings (BPTH) United States $0.042B 0.00
Mannatechorporated (MTEX) United States $0.041B 0.00
Lipocine (LPCN) United States $0.038B 0.00
Melinta Therapeutics (MLNT) United States $0.035B 0.00
ContraFect (CFRX) United States $0.035B 0.00
ProPhase Labs (PRPH) United States $0.035B 0.00
Zomedica Pharmaceuticals (ZOM) United States $0.033B 0.00
IsoRay (ISR) United States $0.031B 0.00
Citius Pharmaceuticals (CTXR) United States $0.030B 0.00
Regulus Therapeutics (RGLS) United States $0.029B 0.00
Heat Biologics (HTBX) United States $0.029B 0.00
HANCOCK JAFFE (HJLI) United States $0.028B 0.00
Achieve Life Sciences (ACHV) United States $0.025B 0.00
Biomerica (BMRA) United States $0.023B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.023B 2.98
PharmAthene (ALT) United States $0.022B 0.00
Onconova Therapeutics (ONTX) United States $0.021B 0.00
NanoViricides (NNVC) United States $0.019B 0.00
CollPlant Holdings Sponsored ADR (CLGN) Israel $0.019B 0.00
Pain Therapeutics (SAVA) United States $0.018B 0.00
Cyanotech (CYAN) United States $0.018B 0.00
Tokai Pharmaceuticals (NVUS) United States $0.018B 0.00
Jaguar Animal Health (JAGX) United States $0.018B 0.00
Shineco (TYHT) China $0.017B 2.81
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.016B 0.00
ESSA Pharma (EPIX) Canada $0.013B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.012B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.012B 3.97
VAXART, INC (VXRT) United States $0.011B 0.00
RXi Pharmaceuticals (PHIO) United States $0.011B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.010B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.010B 0.00
Trillium Therapeutics (TRIL) Canada $0.009B 0.00
Ohr Pharmaceuticals (OHRP) United States $0.009B 0.00
PRECISION THERAPEUTICS INC (AIPT) United States $0.009B 0.00
Xenetic Biosciences (XBIO) United States $0.008B 0.00
Ritter Pharmaceuticals (RTTR) United States $0.008B 0.00
DelMar Pharmaceuticals (DMPI) Canada $0.007B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.005B 0.00
Auris Medical Holding AG (EARS) Switzerland $0.005B 0.00
Midatech Pharma (MTP) United Kingdom $0.005B 0.00
Can-Fite Biopharma (CANF) Israel $0.004B 0.00
Advanced Accelerator Applications (AAAP) France $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00